Furthermore, we examined the expression of surface molecules MHCII, CD80, and CD86 in infiltrating CD45+CD103+ DCs in the Control and sh-Rab27a3 groups of glioblastoma. The gene discussed is PTPRC; the disease is glioblastoma.